CSCO Guidelines Conference | Academician Jinming Yu: From the “Jinan Miracle” in Radiation Therapy to Advancing Immunotherapy and International Collaboration

CSCO Guidelines Conference | Academician Jinming Yu: From the “Jinan Miracle” in Radiation Therapy to Advancing Immunotherapy and International Collaboration

2025.04.29
The 2025 CSCO Guidelines Conference, co-hosted by the Chinese Society of Clinical Oncology (CSCO) and the Beijing Xisike Clinical Oncology Research Foundation, was successfully held in Jinan, April 18–19, 2025. Leading experts from across the country gathered once again to exchange cutting-edge research, discuss clinical hot topics, and witness the release of updated CSCO guidelines. Oncology Frontier had the honor of interviewing the conference chair, CSCO Council President, and Academician Jinming Yu of Shandong Cancer Hospital, who shared insights into proton therapy, combined radiotherapy and immunotherapy, and CSCO’s path toward deeper international collaboration.
CUDA Yanqi Lake Meeting | Professor Liqun Zhou: Advancing the Diagnostic Frontier to Improve Survival in Chinese Prostate Cancer Patients

CUDA Yanqi Lake Meeting | Professor Liqun Zhou: Advancing the Diagnostic Frontier to Improve Survival in Chinese Prostate Cancer Patients

2025.04.25
In recent years, the incidence of prostate cancer in China has continued to rise, creating an urgent need to improve diagnostic and treatment strategies tailored to this growing patient population. At the 5th Annual CUDA Yanqi Lake Meeting (2025), hosted by the Chinese Urological Doctor Association, UroStream invited Professor Liqun Zhou, Institute of Urology, Peking University, to discuss the importance of early screening, optimized diagnostic approaches, and advances in neoadjuvant therapy. His insights point toward practical steps for enhancing the survival and quality of life of prostate cancer patients in China.
Global First, with China’s Participation! Drs. Wenyu Yang & Wenbin An Discuss the Development, Highlights, and Clinical Relevance of the First International Expert Consensus on Pediatric Chronic Phase CML

Global First, with China’s Participation! Drs. Wenyu Yang & Wenbin An Discuss the Development, Highlights, and Clinical Relevance of the First International Expert Consensus on Pediatric Chronic Phase CML

2025.04.25
The recently published “Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations” in the prestigious journal Leukemia marks a historic milestone as the first international expert consensus focused on chronic-phase chronic myeloid leukemia (CML) in children and adolescents.